Colchicum Alkaloids
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Tracing History
Comprehensive Summaries of Uppsala Dissertations from the Faculty of Science and Technology 911 Tracing History Phylogenetic, Taxonomic, and Biogeographic Research in the Colchicum Family BY ANNIKA VINNERSTEN ACTA UNIVERSITATIS UPSALIENSIS UPPSALA 2003 Dissertation presented at Uppsala University to be publicly examined in Lindahlsalen, EBC, Uppsala, Friday, December 12, 2003 at 10:00 for the degree of Doctor of Philosophy. The examination will be conducted in English. Abstract Vinnersten, A. 2003. Tracing History. Phylogenetic, Taxonomic and Biogeographic Research in the Colchicum Family. Acta Universitatis Upsaliensis. Comprehensive Summaries of Uppsala Dissertations from the Faculty of Science and Technology 911. 33 pp. Uppsala. ISBN 91-554-5814-9 This thesis concerns the history and the intrafamilial delimitations of the plant family Colchicaceae. A phylogeny of 73 taxa representing all genera of Colchicaceae, except the monotypic Kuntheria, is presented. The molecular analysis based on three plastid regions—the rps16 intron, the atpB- rbcL intergenic spacer, and the trnL-F region—reveal the intrafamilial classification to be in need of revision. The two tribes Iphigenieae and Uvularieae are demonstrated to be paraphyletic. The well-known genus Colchicum is shown to be nested within Androcymbium, Onixotis constitutes a grade between Neodregea and Wurmbea, and Gloriosa is intermixed with species of Littonia. Two new tribes are described, Burchardieae and Tripladenieae, and the two tribes Colchiceae and Uvularieae are emended, leaving four tribes in the family. At generic level new combinations are made in Wurmbea and Gloriosa in order to render them monophyletic. The genus Androcymbium is paraphyletic in relation to Colchicum and the latter genus is therefore expanded. -
Landscaping Without Harmful Invasive Plants
Landscaping without harmful invasive plants A guide to plants you can use in place of invasive non-natives Supported by: This guide, produced by the wild plant conservation Landscaping charity Plantlife and the Royal Horticultural Society, can help you choose plants that are without less likely to cause problems to the environment harmful should they escape from your planting area. Even the most careful land managers cannot invasive ensure that their plants do not escape and plants establish in nearby habitats (as berries and seeds may be carried away by birds or the wind), so we hope you will fi nd this helpful. A few popular landscaping plants can cause problems for you / your clients and the environment. These are known as invasive non-native plants. Although they comprise a small Under the Wildlife and Countryside minority of the 70,000 or so plant varieties available, the Act, it is an offence to plant, or cause to damage they can do is extensive and may be irreversible. grow in the wild, a number of invasive ©Trevor Renals ©Trevor non-native plants. Government also has powers to ban the sale of invasive Some invasive non-native plants might be plants. At the time of producing this straightforward for you (or your clients) to keep in booklet there were no sales bans, but check if you can tend to the planted area often, but it is worth checking on the websites An unsuspecting sheep fl ounders in a in the wider countryside, where such management river. Invasive Floating Pennywort can below to fi nd the latest legislation is not feasible, these plants can establish and cause cause water to appear as solid ground. -
Research Article
IUFS Journal of Biology Short Communications 53 IUFS J Biol 2011, 70(2):53-61 Morpho-anatomical observations on Colchicum boissieri Orph. in Turkey Ece Sevgi¹* and Orhan Küçüker² ¹Bezmialem Vakıf University, Faculty of Pharmacy, Dept. of Pharmaceutical Botany – Istanbul- Turkey ²Istanbul University, Faculty of Science, Department of Biology, 34134, Süleymaniye, Istanbul- Turkey Abstract In this study, the morpho-anatomical features of Colchicum boissieri Orph. were demonstrated. The morphological characteristics of the corm, leaf, flower, fruit and seeds were presented and the habitus of the species were given by photographs. Corm lengths, cataphyll color and length, leaf color, outer-inner tepal dimension (length x width), perigonium tube dimension, outer-inner filament (length) and anther (length), styles color, seed number, shape, dimension and color were determined. The corm of C. boissieri is soboliferous, occasionally tooth-like projections, vertical, soboles horizontal, 2.3-4.5 cm in length and 0.6-1.4 cm in width. The neck (collum) of the corm is 3-5.5 cm in length. The cataphyll is yellowish-white in color, 3-7.5 cm in length. Perigonium tube is 4.4-13 cm in length. The seeds are that wrinkled surface subglobose to globose in shape, yellowish-brown in color, and (1.3-) 1.4-1.9 mm in diameter. Anatomical characteristics of the corm, leaf, fruit and seeds were shown with photographs. Transverse sections from the middle portion of the corm, leaf, pericarp and seed testa were obtained. The upper and lower surface views of the leaf, pericarp and the seed testa were examined. Anatomical features of C. -
Jānis Rukšāns Late Summer/Autumn 2001 Bulb Nursery ROZULA, Cēsu Raj
1 Jānis Rukšāns Late summer/autumn 2001 Bulb Nursery ROZULA, Cēsu raj. LV-4150 LATVIA /fax + 371 - 41-32260 + 371 - 9-418-440 All prices in US dollars for single bulb Dear friends! Again, we are coming to you with a new catalogue and again we are including many new varieties in it, probably not so many as we would like, but our stocks do not increase as fast as the demand for our bulbs. We hope for many more novelties in the next catalogue. Last season we had one more successful expedition – we found and collected 3 juno irises never before cultivated (we hope that they will be a good addition to our Iris collection) and many other nice plants, too. In garden we experienced a very difficult season. The spring came very early – in the first decade of April the temperature unexpectedly rose up to +270 C, everything came up, flowered and finished flowering in few days and then during one day the temperature fell as low as –80 C. A lot of foliage was killed by a returned frost. As a result the crop of bulbs was very poor. The weather till the end of June was very dry – no rain at all, only hot days followed by cold nights. But then it started to rain. There were days with the relative air humidity up to 98%. The drying of harvested bulbs was very difficult. I was forced to clean one of my living rooms in my house, to heat it and to place there the boxes with Allium and Tulipa bulbs to save them from Penicillium. -
FDHS FLOWER BLOG NO 17 (Pdf)
WELCOME TO BLOG NUMBER 17 IT IS BECOMING QUITE DIFFICULT TO FIND FLOWERS NOW IN THE GARDEN, SO THIS WILL PROBABLY BE THE LAST BLOG FOR A LITTLE WHILE. AND UNFORTUNATELY I HAVE SOME BAD NEWS FOR THOSE OF YOU WHO DON’T ALREADY KNOW. I HAVE BEEN DIAGNOSED WITH BOWEL AND LIVER CANCER AND HAVE JUST STARTED A FAIRLY AGGRESSIVE REGIME OF CHEMOTHERAPY WHICH, WHILST UNABLE TO CURE ME, WILL AT LEAST ENABLE ME TO KEEP GOING AS LONG AS POSSIBLE. I DON’T KNOW YET WHAT SIDE EFFECTS I WILL SUFFER FROM BUT AM HOPING FOR THE BEST. WE ARE BOTH TRYING TO BE VERY POSITIVE, CHEERFUL AND CARRYING ON REGARDLESS. NEITHER OF US DO SYMPATHY VERY WELL, SO KEEP POSITIVE WITH US PLEASE LET’S MOVE ON TO A MORE CHEERFUL SUBJECT AND LOOK AT SOME WONDERFUL AUTUMN FLOWERS ESPECIALLY THE AUTUMN FLOWERING BULBS WHICH ARE PARTICULARLY GOOD THIS YEAR. JEREMY REMEMBER THIS UNPREPOSSING POT OF BULBS I SHOWED YOU IN THE LAST BLOG, I TOOK THIS PICTURE ON 15TH AUGUST JUST BEFORE GIVING IT A SOAK TO REPLICATE THE AUTUMN RAINS IT WOULD HAVE HAD IN SOUTH AFRICA 29TH AUGUST 2ND SEPTEMBER FINALLY IN ALL ITS GLORY;- IT IS HAEMANTHUS COCCINEUS. IT COMES FROM THE WINTER RAINFALL AREA OF THE SOUTHERN CAPE OF SOUTH AFRICA. IT LIKES TO BE POT BOUND AS YOU CAN SEE, AND THE LEAVES ONLY APPEAR AFTER IT HAS FINISHED FLOWERING, THEY ARE QUITE LONG STRAP SHAPED AND BRIGHT GREEN WITH A VERY ATTRACTIVE DARK RED MARKING ON THE UNDERSIDE THERE ARE SO MANY REALLY INTERESTING AND ATTRACTIVE BULBOUS PLANTS FROM SOUTH AFRICA, I CANNOT UNDERSTAND WHY WE DON’T GROW MORE OF THEM IN OUR GARDENS, MANY OF THEM -
Reversal of Neuromuscular Bl.Pdf
JosephJoseph F.F. Answine,Answine, MDMD Staff Anesthesiologist Pinnacle Health Hospitals Harrisburg, PA Clinical Associate Professor of Anesthesiology Pennsylvania State University Hospital ReversalReversal ofof NeuromuscularNeuromuscular BlockadeBlockade DefiniDefinitionstions z ED95 - dose required to produce 95% suppression of the first twitch response. z 2xED95 – the ED95 multiplied by 2 / commonly used as the standard intubating dose for a NMBA. z T1 and T4 – first and fourth twitch heights (usually given as a % of the original twitch height). z Onset Time – end of injection of the NMBA to 95% T1 suppression. z Recovery Time – time from induction to 25% recovery of T1 (NMBAs are readily reversed with acetylcholinesterase inhibitors at this point). z Recovery Index – time from 25% to 75% T1. PharmacokineticsPharmacokinetics andand PharmacodynamicsPharmacodynamics z What is Pharmacokinetics? z The process by which a drug is absorbed, distributed, metabolized and eliminated by the body. z What is Pharmacodynamics? z The study of the action or effects of a drug on living organisms. Or, it is the study of the biochemical and physiological effects of drugs. For example; rocuronium reversibly binds to the post synaptic endplate, thereby, inhibiting the binding of acetylcholine. StructuralStructural ClassesClasses ofof NondepolarizingNondepolarizing RelaxantsRelaxants z Steroids: rocuronium bromide, vecuronium bromide, pancuronium bromide, pipecuronium bromide. z Benzylisoquinoliniums: atracurium besylate, mivacurium chloride, doxacurium chloride, cisatracurium besylate z Isoquinolones: curare, metocurine OnsetOnset ofof paralysisparalysis isis affectedaffected by:by: z Dose (relative to ED95) z Potency (number of molecules) z KEO (plasma equilibrium constant - chemistry/blood flow) — determined by factors that modify access to the neuromuscular junction such as cardiac output, distance of the muscle from the heart, and muscle blood flow (pharmacokinetic variables). -
Summary of Product Characteristics
Health Products Regulatory Authority Summary of Product Characteristics 1 NAME OF THE MEDICINAL PRODUCT Murexal 10 mg/mL solution for injection in pre-filled syringe 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each mL of solution for injection contains 10 mg of suxamethonium chloride anhydrous (as 11 mg of suxamethonium chloride dihydrate). Each 10 ml pre-filled syringe contains 100 mg of suxamethonium chloride anhydrous (as 110 mg of suxamethonium chloride dihydrate). Excipient with known effect: Each ml of solution for injection contains 2.79 mg equivalent to 0.12 mmol of sodium. Each 10 ml pre-filled syringe contains 27.9 mg equivalent to 1.2 mmol of sodium. For the full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Solution for injection (injection). Clear and colourless solution. pH: 3.0 – 4.5 Osmolality: 250-350 mOsm/Kg 4 CLINICAL PARTICULARS 4.1 Therapeutic Indications Murexal is indicated as a muscle relaxant to facilitate endotracheal intubation during induction of general anaesthesia or emergency situations, in adults and paediatric population above 12 years of age. 4.2 Posology and method of administration Suxamethonium should be administered only by or under close supervision of an experienced clinician (anaesthesist, intensivist, emergency physician) familiar with its action, characteristics and hazards, who is skilled in the management of intubation and artificial respiration and only where there are adequate facilities for immediate endotracheal intubation with administration of oxygen by intermittent positive pressure ventilation. It is given intravenously after anaesthesia has been induced and should not be administered to the conscious patient. Posology Adults To achieve endotracheal intubation, suxamethonium chloride is usually administered by bolus intravenous injection in a dose of 1 mg/kg body weight. -
Nijssenbulbs Catalogus2016.Pdf
NIEUWE OOGST NIJSSEN BULBS NIJSSEN BULBS LEGENDA Verklaring van de gebruikte symbolen: (Her)introductie in 2016. Nijssen Bulbs Keurmerk Duurzaam geteeld, met respect voor het milieu. | NIEUWE OOGST Drachtplanten. o.a. honingbijen, wilde bijen en hommels verzamelen volop nectar en stuifmeel uit de bloemen van dit bolgewas. ! Gemiddelde hoogte in cm. De bloei valt in deze periode, @ opgave in maanden. Geadviseerde plantafstand in cm. 2015 2016 # Gemiddelde plantdiepte in cm. $ Waarde geeft de diepte aan van de onderkant van de bol. | BOL- EN KNOLGEWASSEN Herfstbloeier. Bolomvang in cm. % De maat is de omtrek van de bol direct na het rooien. Door vocht verlies kunnen de bollen krimpen naarmate de tijd in de herfst vordert. De grootte wordt gemeten met een bollenmaat: Wanneer er grootte I. wordt aangegeven dan ontvangt u de voor dit seizoen grootst leverbare bollen, die onder normale omstandigheden tot bloei komen. Voorkeurplaatsing: Z Voor een zonnige standplaats. CATALOGUS 2016 Voor een licht beschaduwde L standplaats. NIJSSEN BULBS HEEMSTEDE H Voor in de halfschaduw. WWW.NIJSSENBULBS.NL S Verdraagt volledige schaduw. Bol- en Knolgewassen Een Nieuwe Oogst Nijssen Bulbs Heemstede Bijzondere bol- en knolgewassen Sportparklaan 25a 2103 VR HEEMSTEDE Tel.: 023 - 5471056 Fax: 023 - 5282208 Correspondentie-adres: Postbus 653 2100 AR HEEMSTEDE www.nijssenbulbs.nl [email protected] Catalogus 2016 Catalogus 1 BIJ-VRIENDELIJKE BLOEMBOLLENPAKKETTEN Het belang van biodiversiteit en planten in de tuin waarvan o.a. honingbijen, wilde bijen en hommels stuifmeel en nectar kunnen verzamelen is voor een ieder inmiddels gelukkig duidelijk. Voor u en de bijen zijn de volgende pakketten samengesteld: Bijenpakket voor in potten 20 Crocus sieberi ‘Firefly’ 10 Muscari ‘Baby Breath’ 20 Anemone blanda ‘White Splendour’ 10 Tulipa humilis 20 Ipheion ‘Alberto Castillo’ 20 Chionodoxa ‘Violet Beauty’ Totaal 100 stuks Bestelnr. -
Clinical Pharmacokinetics and Pharmacodynamics CONCEPTS and APPLICATIONS 18048 FM.Qxd 11/11/09 4:31 PM Page Iii
18048_FM.qxd 11/11/09 4:31 PM Page i Clinical Pharmacokinetics and Pharmacodynamics CONCEPTS AND APPLICATIONS 18048_FM.qxd 11/11/09 4:31 PM Page iii FOURTH EDITION Clinical Pharmacokinetics and Pharmacodynamics Concepts and Applications Malcolm Rowland, DSc, PhD Thomas N. Tozer, PharmD, PhD Professor Emeritus Professor Emeritus School of Pharmacy and School of Pharmacy and Pharmaceutical Sciences Pharmaceutical Sciences University of Manchester University of California, San Francisco Manchester, United Kingdom Adjunct Professor of Pharmacology Skaggs School of Pharmacy and Pharmaceutical Sciences University of California San Diego With Online Simulations by Hartmut Derendorf, PhD Distinguished Professor Guenther Hochhaus, PhD Associate Professor Department of Pharmaceutics University of Florida Gainesville, Florida 18048_FM.qxd 11/11/09 4:31 PM Page iv Acquisitions Editor: David B. Troy Product Manager: Matt Hauber Marketing Manager: Allison Powell Designer: Doug Smock Compositor: Maryland Composition Inc./ASI Fourth Edition Copyright © 2011 Lippincott Williams & Wilkins, a Wolters Kluwer business 351 West Camden Street 530 Walnut Street Baltimore, MD 21201 Philadelphia, PA 19106 Printed in China All rights reserved. This book is protected by copyright. No part of this book may be reproduced or transmitted in any form or by any means, including as photocopies or scanned-in or other electronic copies, or utilized by any information storage and retrieval system without written permission from the copyright owner, except for brief quotations embodied in critical articles and reviews. Materials appearing in this book prepared by individuals as part of their official duties as U.S. government em- ployees are not covered by the above-mentioned copyright. To request permission, please contact Lippincott Williams & Wilkins at 530 Walnut Street, Philadelphia, PA 19106, via email at permis- [email protected], or via website at lww.com (products and services). -
Bulb Log 3818
SRGC ----- Bulb Log Diary ----- ISSN 2514-6114 Pictures and text © Ian Young BULB LOG 38.....................19th September 2018 Autumn Colchicum I feature a portrait of Colchicum agrippinum on the cover to show how the autumn flowering colchicum can flower without water; in fact they do not even need to be planted to know when to flower. I would not recommend this as the ideal treatment but it is fun to observe the growth like this. I will plant this as the flowers fade and the roots will grow when they detect water. I have more than one form of Colchicum agrippinum - this planting is the same clone as the one shown on the cover and it is more prolific in its rate of increase than the other form which, in my view, has the better marked flowers. Colchicum agrippinum Note the paler, less distinct tessellations of the Colchicum agrippinum flowers above compared to the form below which also has dark style, filaments and pollen this form also has more rounded tips to the petals. It is suggested that Colchicum agrippinum is a hybrid between C. variegatum and C. autumnale and it is entirely possible that there is more than one such hybrid. Colchicum agrippinum Colchicum tessellated hybrid The naming of cultivated forms of colchicum, as with so many plants, can become confused and you will find lots of very similar looking plants being distributed under different names. While I understand the need for order I have a relaxed attitude to cultivar names and if I like a plant I am happy to grow it without the need to know its name. -
Drug Administration in Cataract Surgery* by L
Br J Ophthalmol: first published as 10.1136/bjo.43.5.302 on 1 May 1959. Downloaded from Brit. J. Ophthal. (1959) 43, 302. DRUG ADMINISTRATION IN CATARACT SURGERY* BY L. P. AGARWAL, R. B. L. GUPTA, AND S. R. K. MALIK From the Department of Ophthalmology, All-India Institute ofMedical Sciences, New Delhi, India THE problem of cataract surgery in India is immense. Great economic loss is caused by improper and inadequate surgery, and through lack of education, the cooperation of the patient is not all one would like it to be. Vitreous prolapse occurs in 7 to 9 per cent. of routinely-sedated patients, and iris prolapse in about 4 per cent., where a peripheral iridectomy has been done and a stitch applied. The visual results are often poor and ophthalmic surgeons tend to lay the blame on the patient. With all the means at our disposal to-day, however, this is rather unfair, and we have managed to obtain better relaxation by operating under curare akinesia. We have been fortunate in not meeting many complications (Agarwal and Mathur, 1952; Agarwal, 1953), but the use of curare alone in the doses usually given is not without risk, nor does it eliminate post-opera- tive hazards. Chlorpromazine (Agarwal, Gupta, and Malik, 1957) has also given encouraging results when used for sedation, and both drugs lowered the intra-ocular pressure to safe limits even when it was high initially. We have also had some success with acetazoleamide used before and after http://bjo.bmj.com/ operation (Agarwal, and Malik, 1957; Agarwal, Sharma, and Malik, 1955). -
Practical Guidance for the Evaluation and Management of Drug Hypersensitivity: Specific Drugs
Specific Drugs Practical Guidance for the Evaluation and Management of Drug Hypersensitivity: Specific Drugs Chief Editors: Ana Dioun Broyles, MD, Aleena Banerji, MD, and Mariana Castells, MD, PhD Ana Dioun Broyles, MDa, Aleena Banerji, MDb, Sara Barmettler, MDc, Catherine M. Biggs, MDd, Kimberly Blumenthal, MDe, Patrick J. Brennan, MD, PhDf, Rebecca G. Breslow, MDg, Knut Brockow, MDh, Kathleen M. Buchheit, MDi, Katherine N. Cahill, MDj, Josefina Cernadas, MD, iPhDk, Anca Mirela Chiriac, MDl, Elena Crestani, MD, MSm, Pascal Demoly, MD, PhDn, Pascale Dewachter, MD, PhDo, Meredith Dilley, MDp, Jocelyn R. Farmer, MD, PhDq, Dinah Foer, MDr, Ari J. Fried, MDs, Sarah L. Garon, MDt, Matthew P. Giannetti, MDu, David L. Hepner, MD, MPHv, David I. Hong, MDw, Joyce T. Hsu, MDx, Parul H. Kothari, MDy, Timothy Kyin, MDz, Timothy Lax, MDaa, Min Jung Lee, MDbb, Kathleen Lee-Sarwar, MD, MScc, Anne Liu, MDdd, Stephanie Logsdon, MDee, Margee Louisias, MD, MPHff, Andrew MacGinnitie, MD, PhDgg, Michelle Maciag, MDhh, Samantha Minnicozzi, MDii, Allison E. Norton, MDjj, Iris M. Otani, MDkk, Miguel Park, MDll, Sarita Patil, MDmm, Elizabeth J. Phillips, MDnn, Matthieu Picard, MDoo, Craig D. Platt, MD, PhDpp, Rima Rachid, MDqq, Tito Rodriguez, MDrr, Antonino Romano, MDss, Cosby A. Stone, Jr., MD, MPHtt, Maria Jose Torres, MD, PhDuu, Miriam Verdú,MDvv, Alberta L. Wang, MDww, Paige Wickner, MDxx, Anna R. Wolfson, MDyy, Johnson T. Wong, MDzz, Christina Yee, MD, PhDaaa, Joseph Zhou, MD, PhDbbb, and Mariana Castells, MD, PhDccc Boston, Mass; Vancouver and Montreal,